retatrutide phase 2 trial duration weight loss type diabetes 2 results 2024 ada demonstrate benefits of in obesity, diabetes, NASH Efficacy and Safety of Retatrutide – retatrutide phase 2 trial type – Triple hormone receptor agonist retatrutide

Women of childbearing age who are taking GLP-1 medications should discuss pregnancy planning openly with their healthcare team

However, patients taking this medication may notice changes in bowel habits and stool characteristics due to altered gastrointestinal transit time and digestive processes

The authors have verified a lower relative abundance of Bacteroidetes in the steatohepatitis group

About Direct Meds Direct Meds is a US-based telemedicine provider that connects you with prescription medications online

Although real-world flexibility can benefit some patients, it should not replace evidence-based protocols entirely